PRospective Observational Multicentre Study on VAriability of Lung Function in Stable PCD Patients (PROVALF-PCD)
Sponsor: Assistance Publique - Hôpitaux de Paris
A observational or N/A phase clinical study on Primary Ciliary Dyskinesia, this trial is ongoing. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 7 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Dec 2024 — Present [monthly]
Unknown
-
Sep 2024 — Dec 2024 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Unknown Status
▶ Show 2 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Nov 2018 — Nov 2020 [monthly]
Active Not Recruiting
First recorded
Aug 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
- Bambino Gesù Hospital and Research Institute
- Copenhagen University Hospital, Denmark
- Federico II University
- Hacettepe University
- Hospital Vall d'Hebron
- Marmara University
- Meyer Children's Hospital IRCCS
- Royal Brompton & Harefield NHS Foundation Trust
- Ruhr University of Bochum
- Universidade Nova de Lisboa
- Universitaire Ziekenhuizen KU Leuven
- University Hospital Muenster
- University Hospital, Motol
- University of Bern
- University of Cyprus
- University of Melbourne
- University of Southampton
- University of Sydney
- University of Valencia
For direct contact, visit the study record on ClinicalTrials.gov .